Odyssey Investment Partners Acquires BarrierSafe Solutions International
Odyssey Investment Partners, LLC announces that it has acquired BarrierSafe Solutions International, Inc., a provider of disposable gloves, from Linden Capital Partners and The Edgewater Funds. Financial terms of the transaction were not disclosed.
Based in Lake Forest, Ill., BarrierSafe is a player in the $2 billion U.S. disposable protective glove segment of the personal protective equipment industry. The company designs, develops and markets a comprehensive suite of disposable gloves and other related products that serve the needs of users across a diverse range of growing, niche markets that enjoy favorable regulatory and secular tailwinds. Formed in 2004 through the merger of two industry leaders, Microflex and FoodHandler, BarrierSafe today provides in excess of six billion single-use gloves annually.
Odyssey has prior experience in the personal protective equipment industry through its investment in Norcross Safety Products, a leading provider of safety products to the fire, general safety and electric utility end markets. Norcross was sold to Honeywell International in 2008. Robert Peterson and David Myers, Norcross' former CEO and CFO, respectively, are co-investing with Odyssey and will join the BarrierSafe board of directors.
Randy Paulson, managing principal of Odyssey, says, "We are excited to invest again in the safety sector through BarrierSafe and to partner with the Company's extremely talented management team. We expect to create value for our investors by capitalizing on BarrierSafe's strong market positions and compelling growth opportunities, including acquisitions."
The BarrierSafe management team, led by CEO Mike Mattos and CFO/COO Joe Kubicek, will continue to lead the company under Odyssey's ownership. The management team has invested in BarrierSafe alongside Odyssey.
Debt financing for the transaction will consist of a senior secured facility led by CIT Capital and SunTrust and mezzanine financing provided by Morgan Stanley Credit Partners.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
